E
(1; TRA); Neuralgia (f; PHR); Otosis (1; BGB); Pain (1; CRC; TRA); Pertussis (f; PHR); Pharyn-
gosis (1; APA; BGB); Phthisis (f; CRC); Pulmonosis (1; CRC; JFM); Respirosis (2; KOM; PIP;
TRA); Rheumatism (2 [EO topical]; JFM; KOM; PHR); Rhinosis (f; CRC); Ringworm (1; APA);
Scarlet Fever (f; PHR); Sinusosis (1; PHR); Sore (1; APA; CRC; JFM); Sore Throat (1; APA;
CRC); Spasm (f; CRC); Stomatosis (1; APA); Syncope (1; FNF); Tuberculosis (f; CRC); Tumor
(1; APA); Vaginosis (f; CRC); Virus (1; APA; JBU; PHR); Water Retention (1; PHR); Worm (1;
CRC; HHB; PHR; TRA; WBB); Wound (f; CRC).
Dosages (Eucalyptus) — 1–2 tsp chopped leaf/cup water (APA); 4–6 g leaf/day (KOM; PIP);
4–16 g leaf/day (PHR); 300–600 mg EO (PHR); 1–2 drops EO/cup water; 0.05–0.2 ml EO (CAN;
PNC); 0.05–0.2 ml eucalyptol (cineole) (CAN); 2–4 g fluid extract (CAN); single dose 2 g (HHB);
3–9 g tincture (KOM); 3–4 g tincture/day (PHR); steep 8–10 g dry leaf/liter water or 30–40 g fresh
leaf, inhale the steam (TRA).
Contraindications, Interactions, and Side Effects (Eucalyptus) — Class 2d. Contraindicated in
inflammatory diseases of the bile duct, GI tract, and liver. Do not use near nostrils of infants (AHP).
CAN cautions that the oil can cause nausea and vomiting, and should not be taken internally during
pregnancy or lactation. “Undiluted eucalyptus oil is toxic and should not be taken internally unless
suitably diluted. A dose of 3.5 ml has proved fatal.” (CAN) Symptoms of poisoning include
abdominal pain, bronchospasm, convulsions, cyanosis, delirium, dizziness, epigastric burning,
myosis, muscular weakness, respiratory problems, spontaneous vomiting, tachypnea with severe
respiratory depression, and a feeling of suffocation. May interfere with hypoglycemic therapy
(CAN). Eucalyptus oil causes induction of the foreign-substance degrading enzyme system in the
liver. This may weaken and/or shorten the activity of other medicinal agents; may cause diarrhea,
nausea, and vomiting (PIP). CNS effects include diminution or loss of reflexes and depression of
consciousness, possibly progressing to coma. Fatalities have been reported in adults ingesting as
little as 4–5 ml eucalyptus oil; 30 ml will usually cause death (AEH1).
Extracts (Eucalyptus) — In vivo, quercitrin and hyperoside have shown antiviral activity against
influenza type A (CAN). Euglobulin reported to be antiinflammatory, antiproliferative, and to inhibit
in vitro TPA-induced EBV-EA activity in animal studies (PHR). Cineole is antispasmodic, bacte-
ricide, fungicide, secretogogic, secretolytic, and rubefacient (SHT).
EUPHORBIA (Chamaesyce hirta (L.) Millsp.) +Synonyms — Euphorbia hirta L., E. pilulifera L.
Activities (Euphorbia) — Amebicide (1; KAP); Anthelminthic (1; KAP); Anticancer (1; KAP);
Antileukemic (1; KAP); Antipyretic (f; KAB); Astringent (f; KAB); Bronchodilator (f; KAB);
Cardiodepressant (1; KAB); Emetic (1; KAB); Expectorant (f; KAP); Hemostat (f; KAB); Hypogly-
cemic (1; KAP); Lactagogue (f; DEP; KAB); Mastogenic (f; IED); Myorelaxant (1; KAP); Narcotic
(f; DEP; KAB); Respiradepressant (1; KAB); Sedative (f; KAB).
Indications (Euphorbia) — Adenopathy (f; KAB); Ameba (1; KAP); Aphtha (f; KAB); Arthrosis
(f; DAV); Asthma (f; DEP; KAB; KAP); Bleeding (f; KAB); Boil (f; SKJ); Bronchosis (f; KAB;
KAP); Cancer (1; JLH; KAP; MPI); Cold (f; KAP); Colic (f; KAB; MPI); Corn (f; JLH); Cough
(f; DEP; KAB; KAP); Dermatosis (f; SKJ); Diarrhea (f; KAB); Dysentery (f; KAB; KAP); Edema
(f; KAB); Enterosis (f; KAB); Fever (f; KAB); Fungus (f; SKJ); Gonorrhea (f; DEP); Hyperglycemia
(1; KAP); Inflammation (f; KAB); Insomnia (f; KAB); Leukemia (1; KAP); Mucososis (f; KAB);
Nephrosis (f; SKJ); Nervousness (f; KAB); Ophthalmia (f; KAB; JLH); Respirosis (f; KAB);
Rheumatism (f; DAV); Ringworm (f; SKJ); Sore (f; KAB); Stomatosis (f; SKJ); Urogenitosis (f;
KAB); VD (f; DEP); Vomiting (f; DEP; KAB); Wart (f; KAB; MPI); Worm (f; KAB); Wound (f; JLH).